Good morning :)
Switch to
Place Order

Laurus Labs Ltd

LAURUSLABS
Health CarePharmaceuticals
MidcapWith a market cap of ₹34,761 cr, stock is ranked 137
Moderate RiskStock is 2.84x as volatile as Nifty
647.805.80 (-0.89%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹34,761 cr, stock is ranked 137
Moderate RiskStock is 2.84x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
35.34
PB RatioPB Ratio
13.37
Dividend YieldDiv. Yield
0.31%
Sector PESector PE
40.61
Sector PBSector PB
5.75
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Investor PresentationView older 

Apr 29, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020212.092.312.844.840.170.090.260.98
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.45%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnJul 16, 2021

Laurus Labs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 15, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Laurus Labs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 15, 2021. Further, the company has informed the Exchange regarding voting results. | Download

Shareholders meeting 
Announced OnJul 15, 2021

Laurus Labs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 15, 2021 | Download

Laurus Labs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 15, 2021 | Download

Cash Dividend 
Ex. DateMay 11, 2021

Interim 3 • Div/Share: ₹ 0.8

See all events